Thus, our observation that downregulated SFRP5 levels were associated with elevated E/E’ may suggest a new molecular pathway underlying the nexus between obesity/metabolic syndrome and diastolic dysfunction/HFpEF. This evidence concerns the gene SFRP5 and obesity disorder.